Orders for Merck ... suggested the drug was not as effective as previously thought. A 30% reduction in the risk of hospitalisation or death in people with mild or moderate COVID-19 at high ...

A new way to combat COVID-19 Doctors have said they ... group of independent experts to debate and vote on Merck's drug on November 30. That panel narrowly voted 13-10 in favor of authorization ...

An FDA advisory panel has voted in favour of Merck & Co's experimental insomnia drug, saying that it is safe and effective for elderly patients at the lower of two doses studied.